| Literature DB >> 35923452 |
Julia Hemmers1, Christopher Baethge2, Kai Vogeley2,3, Christine M Falter-Wagner1,4.
Abstract
Executive functions (EF) have been shown to be important for the understanding of Autism Spectrum Disorder (ASD), but dysfunctions of EF are not autism-specific. The specific role of EF in ASD, its relationship to core autism characteristics, such as mentalizing, needs to be explored. Medline- and PsychINFO databases were searched for studies published between 1990 and 2020 that included measures of EF in ASD and typically developing control persons (TD) in combination with either Theory of Mind (ToM) or Weak Central Coherence (WCC) tasks. A pre-registered meta-analysis and cross-study regression was performed including a total of 42 studies (ASD n = 1,546, TD n = 1,206). Results were reported according to PRISMA guidelines. In all cognitive domains, the ASD group showed significantly reduced performance. Importantly, EF subdomains and ToM were not significantly correlated. This finding rules out a significant association between EF subdomains and ToM and questions the relevance of EF dysfunctions for the autism-specific feature of reduced mentalizing.Entities:
Keywords: autism (ASD); cognitive profile; executive function; theory of mind; weak central coherence
Year: 2022 PMID: 35923452 PMCID: PMC9342604 DOI: 10.3389/fpsyt.2022.886588
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 5.435
Search terms.
| ASD | Executive function | Theory of mind | Central coherence |
| -Autis | -Response | TOM | -local/global |
PDD NOS, pervasive developmental disorder not otherwise specified; ASD, autism spectrum disorder; WCST, Wisconsin card sorting task; TOM, theory of mind; RMET, reading the mind in the eyes task. *To cover a broader spectrum of search term endings.
FIGURE 1Funnel plot of studies comparing Executive Function performance between ASD and TD. SMD, standard mean difference (Effect Size); SE, standard error; EF1, inhibition; EF2, working memory; EF3, flexibility; EF4, planning. Positive effect sizes indicate superior performance in ASD. The solid vertical line indicates the estimate for the population effect size.
FIGURE 3Funnel plot–theory of mind funnel plot for 26 studies comparing theory of mind performance between ASD and TD. SMD, standard mean difference (effect size); SE, standard error. Positive effect sizes indicate superior performance in ASD. The solid vertical line indicates the estimate for the population effect size.
FIGURE 4PRISMA flowchart.
FIGURE 5Forest plot–executive function: subgroup analysis of EF domains. Results show medium effect size measures for all EF subtypes observed. Graphical explanations: horizontal lines present 95% confidence Interval of the effect sizes for each study; green dot: hedges‘g; diamond shape: overall effect size.
Included studies.
| ASD | Group | TD | Group | Cognitive | Construct | |||||||||
| Source and publication | Diagnostic criteria | NOS scale |
|
| Inhibition | Working memory | Flexibility | Planning | ToM | CC | ||||
| Baez et al. ( | DSM IV | 6 (good) | 15 | 35.46 (11.86) | - | 15 | 35.7 (11.52) | - | X | X | X | |||
| Beaumont and Sofronoff ( | DSM IV | 7 (good) | 25 | 9.52 (0.88) | 114 (12.26) | 9.52 (0.88) | 119.69 (10.49) | X | x | |||||
| Berenguer et al. ( | ADI-R | 7 (good) | 52 | 8.59 (1.38) | 101.42(12.65) | 37 | 8.54 (1.26) | 102.11 (8.91) | X | X | X | X | X | |
| Berenguer et al. ( | ADI-R | 7 (good) | 30 | 8.39(1.3) | 100.37 (12.4) | 37 | 8.54 (1.2) | 102.11 (8.9) | X | X | X | X | X | |
| Beversdorf et al. ( | ADI-R | 6 (good) | 10 | 30.8 (9.3) | 109.7 (16.2) | 13 | 30.6 (12) | 117.3 (11.2) | X | |||||
| Brunsdon et al. ( | ADOS | 6 (good) | 181 | 13.49 (0.69) | 94.07 (16.91) | 160 | 12.79 (1.1) | 102 (12.79) | X | X | X | X | X | |
| Cantio et al. ( | DSM IV | 8 (good) | 21 | 10.7 (1.5) | 105.48 (15.95) | 30 | 10.96 (1.26) | 109.47 (18.58) | X | X | X | X | ||
| Durrleman and Franck ( | DSM IV | 6 (good) | 17 | 9 (2) | - | 17 | 7.2 (xx) | - | X | X | X | |||
| Edgin and Pennington ( | ADI-R | 6 (good) | 24 | 11.46 (2.32) | 104.4 (20.4) | 34 | 12.4 (2.52) | 108.72 (13.04) | X | X | ||||
| Gonzalez-Gadea et al. ( | DSM IV | 7 (good) | 23 | 33 (9.8) | - | 21 | 38.3 (14.2) | - | X | X | X | |||
| Gonzalez-Gadea et al. ( | DSM IV | 7 (good) | 19 | 11.89 (2.64) | 101.93 (11.96) | 19 | 10.89 (2.3) | 100.59 (12.2) | X | X | X | X | ||
| Hanson and Atance ( | DSM IV | 5 (fair) | 25 | 5.2 (1.49) | 85.71 (21) | 25 | 4.1 (0.93) | 109.12 (8) | X | X | X | X | X | |
| Jones Catherine et al. ( | ICD -10 | 2 (poor) | 100 | 15.6(0.6) | 84.31 (18.03) | - | - | - | X | X | X | x | X | |
| Joseph and Tager-Flusberg ( | DSM IV | 2 (poor) | 31 | 8.9 (2.5) | 88 (22.8) | - | - | - | X | X | X | |||
| Kouklari et al. ( | DSM IV DSM V | 6 (good) | 45 | 9.07 (1.42) | 97.05 (12.13) | 37 | 9.03 (1.17) | 102.11 (14.3) | X | X | X | X | ||
| Kouklari et al. ( | DSM IV | 6 (good) | 32 | 10.34 (1.29) | 100.69 (12.85) | 32 | 10 (1.35) | 114.81 (9.98) | X | X | X | X | ||
| Kimhi ( | DSM IV | 7 (good) | 29 | 4.95 (11.06) | 103.52(17.21) | 30 | 4.6 (10.97) | 107.6 (14.13) | X | X | ||||
| Lam ( | - | 4 (fair) | 16 | 8.9 (1.41) | 108.44 (12.76) | 16 | 8.42 (2.07) | 109.75 (12.58) | X | X | ||||
| Lam and Yeung ( | - | 5 (fair) | 12 | 6.11 (8.23) | 70.17 (3.51) | 12 | 5.64 (1) | 77.91 (3.04) | X | X | ||||
| Low et al. ( | DSM IV | 6 (good) | 27 | 8.26 (2.17) | - | 27 | 6.6 (1.31) | - | X | X | X | |||
| Lai et al. ( | - | 6 (good) | 64 | 28.15 (6.1) | 114.15 (11.15) | 64 | 27.55 (7.7) | 113.5 (14.9) | X | X | ||||
| Lukito et al. ( | ADI-R | 2 (poor) | 100 | - | 84.3(18) | - | - | - | X | X | X | X | X | |
| Le Sourn-Bissaoui et al. ( | DSM IV | 6 (good) | 10 | 16.1 (3.5) | 101.8(17.06) | 10 | 15.9 (3.6) | 98.4 (10.9) | ||||||
| Lind et al. ( | DSM IV | 6 (good) | 20 | 8.67 (1.37) | 105.65(16.34) | 20 | 8.31 (0.91) | 109.05 (8.68) | X | |||||
| Livingston et al. ( | - | 6 (good) | 136 | 13.28 (0.39) | - | 136 | 13.28 (0.39) | - | X | x | X | X | X | |
| Loth et al. ( | DSM IV | 2 (poor) | 21 | 16.8 (6.2) | 89.9(23.4) | 10 | 6.3 (1.1) | - | X | |||||
| Lehnhardt et al. ( | ICD-10 | 6 (good) | 39 | 31.1 (8.9) | 127.9(16.2) | 39 | 31.2 (8.1) | 133.3 (11.6) | X | x | ||||
| Miranda et al. ( | - | 7 (good) | 52 | 8.59 (1.38) | 101.42 (12.65) | 39 | 8.46 (1.27) | 102.21 (8.7) | x | x | ||||
| Montgomery et al. ( | - | 2 (poor) | 25 | 18.2 (1.38) | 114(11.1) | - | - | - | X | |||||
| Narzisi et al. ( | DSM IV | 7 (good) | 22 | 9.77 (3.65) | 99.09(14.23) | 40 | 9.77 (3.65) | X | X | X | X | |||
| Ozonoff et al. ( | DSM III | 6 (good) | 23 | 12.05 (3.19) | 89.52(15.17) | 20 | 12.39 (3.04) | 91.3 (18.75) | x | X | X | |||
| Pellicano ( | - | 7 (good) | 30 | 5.63 (0.97) | 100.03 (10.55) | 40 | 5.47 (0.95) | 103.25 (9.92) | X | X | X | X | ||
| Pellicano ( | DSM IV | 4 (poor) | 45 | 5.42 (0.87) | 113.27(13.93) | 45 | 5.43 (1.05) | 115.61 (16.42) | X | X | X | X | X | |
| Pellicano ( | DSM IV | 6 (good) | 45 | 5.6 (0.87) | 113.27 (13.93) | - | - | - | X | X | X | X | ||
| Pellicano et al. ( | DSM IV | 6 (good) | 40 | 5.59 (0.83) | 101.15 (11.04) | 40 | 5.47 (0.95) | 103.25 (9.91) | X | X | X | X | X | |
| Schuwerk et al. ( | ICD-10 | 7 (good) | 14 | 8 (1.8) | - | 21 | 7.2 (1.4) | - | X | |||||
| Stichter et al. ( | ADI-R | 4 (poor) | 20 | 8.77 (1.3) | 99.3(15.18) | - | - | - | X | X | X | X | X | |
| Vanmarcke et al. ( | DSM IV | 5 (fair) | 24 | 20.63(0.38) | 107.63(8.7) | 24 | 20.83 (0.41) | 108.9 (6.05) | X | X | X | X | X | |
| Vanegas and Davidson ( | - | 7 (good) | 24 | 9.7 (1.35) | 100.72 (14.32) | 25 | 8.86 (1.09) | 110.12 (14.59) | X | X | X | X | X | |
| Williams et al. ( | - | 5 (fair) | 21 | 10.6 (2.01) | 110.19(16.35) | 21 | 10.59 (1.31) | 107.48 (13.23) | X | X | ||||
| Yang et al. ( | DSM IV | 6 (good) | 20 | 15.5 (8.1) | 96.68 (24.63) | 30 | 8 (3.1) | 118.23 (12.06) | X | X | X | X | ||
| Zelazo et al. ( | DSM III–R | 2 (poor) | 22 | 13.88 (4.75) | 42.59 (13.32) | - | - | - | X | X | X |
This Table presents Demographics of the samples observed and the cognitive Constructs that were measured for each study. ASD, autism spectrum disorder; TD, typically developing; NOS, Newcastle Ottawa scale; ToM, theory of mind; CC, central coherence.